107 related articles for article (PubMed ID: 7718319)
1. Psychological reactions in patients with malignant melanoma.
Brandberg Y; Månsson-Brahme E; Ringborg U; Sjödén PO
Eur J Cancer; 1995; 31A(2):157-62. PubMed ID: 7718319
[TBL] [Abstract][Full Text] [Related]
2. Psychological reactions in public melanoma screening.
Brandberg Y; Bolund C; Michelson H; Månsson-Brahme E; Ringborg U; Sjödén PO
Eur J Cancer; 1993; 29A(6):860-3. PubMed ID: 8484978
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma.
Bergenmar M; Nilsson B; Hansson J; Brandberg Y
Acta Oncol; 2004; 43(2):161-8. PubMed ID: 15163164
[TBL] [Abstract][Full Text] [Related]
4. Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients.
Tesio V; Ribero S; Castelli L; Bassino S; Leombruni P; Caliendo V; Grassi M; Lauro D; Macripò G; Torta RGV
Melanoma Res; 2017 Jun; 27(3):277-280. PubMed ID: 28207426
[TBL] [Abstract][Full Text] [Related]
5. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.
Beesley VL; Smithers BM; Khosrotehrani K; Khatun M; O'Rourke P; Hughes MC; Malt MK; Zonta MJ; Bayley GJ; Barbour AP; Brown LJ; D'Arcy J; Allan CP; Green AC
Psychooncology; 2015 Jul; 24(7):763-70. PubMed ID: 25355178
[TBL] [Abstract][Full Text] [Related]
6. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
[TBL] [Abstract][Full Text] [Related]
7. A quality-of-life study in high-risk (thickness > = or 2 mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins.
Newton-Bishop JA; Nolan C; Turner F; McCabe M; Boxer C; Thomas JM; Coombes G; A'Hern RP; Barrett JH
J Investig Dermatol Symp Proc; 2004 Mar; 9(2):152-9. PubMed ID: 15083783
[TBL] [Abstract][Full Text] [Related]
8. The role of psychological variables in a group of melanoma patients. An Israeli sample.
Baider L; Perry S; Sison A; Holland J; Uziely B; DeNour AK
Psychosomatics; 1997; 38(1):45-53. PubMed ID: 8997116
[TBL] [Abstract][Full Text] [Related]
9. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
[TBL] [Abstract][Full Text] [Related]
10. Fear of new or recurrent melanoma after treatment for localised melanoma.
Bell KJL; Mehta Y; Turner RM; Morton RL; Dieng M; Saw R; Guitera P; McCaffery K; Low D; Low C; Jenkins M; Irwig L; Webster AC
Psychooncology; 2017 Nov; 26(11):1784-1791. PubMed ID: 28052599
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
[TBL] [Abstract][Full Text] [Related]
12. Patients highly value routine follow-up of skin cancer and cutaneous melanoma.
Themstrup L; Jemec GE; Lock-Andersen J
Dan Med J; 2013 Oct; 60(10):A4713. PubMed ID: 24083527
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma.
Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
Prog Clin Biol Res; 1984; 156():169-79. PubMed ID: 6473424
[No Abstract] [Full Text] [Related]
14. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness.
Swetter SM; Johnson TM; Miller DR; Layton CJ; Brooks KR; Geller AC
Arch Dermatol; 2009 Apr; 145(4):397-404. PubMed ID: 19380661
[TBL] [Abstract][Full Text] [Related]
15. Psychological factors in the prognosis of malignant melanoma: a prospective study.
Rogentine GN; van Kammen DP; Fox BH; Docherty JP; Rosenblatt JE; Boyd SC; Bunney WE
Psychosom Med; 1979 Dec; 41(8):647-55. PubMed ID: 545425
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
[TBL] [Abstract][Full Text] [Related]
17. Follow-up in stage I cutaneous malignant melanoma: an audit.
Baughan CA; Hall VL; Leppard BJ; Perkins PJ
Clin Oncol (R Coll Radiol); 1993; 5(3):174-80. PubMed ID: 8347541
[TBL] [Abstract][Full Text] [Related]
18. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
[TBL] [Abstract][Full Text] [Related]
19. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.
Beesley VL; Smithers BM; O'Rourke P; Janda M; Khosrotehrani K; Green AC
Support Care Cancer; 2017 Jan; 25(1):93-102. PubMed ID: 27562298
[TBL] [Abstract][Full Text] [Related]
20. Information to patients with malignant melanoma: a randomized group study.
Brandberg Y; Bergenmar M; Bolund C; Michelson H; Månsson-Brahme E; Ringborg U; Sjödén PO
Patient Educ Couns; 1994 Jun; 23(2):97-105. PubMed ID: 21207908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
